Research > Neurosciences

Neuroimmunology

Number of publications
136
Publications search

  • Oreja-Guevara, C; Landete, L; Sagrado, MAR; Moya, I; Revilla, BA; Real, HD; Pinto, MLB; Harty, G; Fenwick, E; Sigworth, E; Ruiz, LB

    From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis

    JOURNAL OF MEDICAL ECONOMICS 29 1764-1778. .

    [doi:10.1080/13696998.2026.2688699]

  • Torres, P; Sánchez, AG; Sancho-Saldaña, A; Quibus, L; Murillo, ES; Ruiz-Fernández, E; Peralta, S; Solana, MJ; Brieva, L; González-Mingot, C

    18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis

    MOLECULAR NEUROBIOLOGY 63 -. .

    [doi:10.1007/s12035-026-05915-8]

  • Costa-Frossard, L; Brieva, L; García-Estévez, DA; Martín-Martínez, JM; Alvarez-Bravo, G; Blasco-Quílez, MR; Meca-Lallana, JE; Calles-Hernández, MC; Tello, CR; Muñoz-Fernández, C; Barbero, DE; López-Muñoz, P; González, JMP; Candeliere-Merlicco, A; Carmona, O; Riancho, J; Sola-Valls, N; Carcelén-Gadea, M; Borrega, L; Gascón-Giménez, F; Vilanova, D; Pérez, X; Villar, LM

    Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 27 -. .

    [doi:10.3390/ijms27114933]

  • Strijbis, E; Mostert, J; D'Haeseleer, M; Moral, E; Ruiz, LB; Comtois, J; Killestein, J; Repovic, P; McPherson, T; Cutter, G; Koch, M

    Diminishing returns of disease-modifying treatment in older participants of MS clinical trials

    Multiple Sclerosis Journal 32 429-439. .

    [doi:10.1177/13524585261429245]

  • Fernández, O; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Hernández, MA; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Vilaseca, A; Rodríguez-Antigüedad, A

    XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)

    REVISTA DE NEUROLOGIA 81 39227-39227. .

    [doi:10.31083/RN39227]

  • Fernández, O; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Hernández, MA; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Vilaseca, A; Rodríguez-Antigüedad, A

    XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)

    REVISTA DE NEUROLOGIA 81 39228-39228. .

    [doi:10.31083/RN39228]

  • Mostert, J; Strijbis, EM; D'Haeseleer, M; Moral, E; Brieva, L; Comtois, J; Repovic, P; Bowen, JD; Cutter, G; Koch, M

    Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset

    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 97 229-238. .

    [doi:10.1136/jnnp-2025-336660]

  • Torres, P; Pradas, I; Fernàndez-Bernal, A; Povedano, M; Dominguez, R; Jové, M; Gonzalez-Mingot, C; Ayala, V; Ferrer, I; Pamplona, R; Portero-Otin, M

    Exploring platelet metabolomics and fatty acid profiles for ALS prognosis and diagnosis

    Scientific Reports 15 34236-34236. .

    [doi:10.1038/s41598-025-16220-0]

  • Gómez-Ballesteros, R; de la Maza, SS; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; Rodríguez-Regal, A; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; Castillo-Triviño, T; Maurino, J

    Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis

    Frontiers in Psychiatry 16 1565150-1565150. .

    [doi:10.3389/fpsyt.2025.1565150]

  • Sancho-Saldaña, A; Gil-Sánchez, A; Quirant-Sánchez, B; Boigues, M; Canudes, M; Peralta, S; Solana, MJ; González-Mingot, C; Quibus, L; Martínez-Cáceres, E; Torres, P; Hervás, JV; Moreno-Magallon, J; Brieva, L

    Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months

    Journal of Clinical Medicine 14 -. .

    [doi:10.3390/jcm14113736]

  • Leavitt, VM; Fox, R; Mostert, J; D'Haeseleer, M; Moral, E; Brieva-Ruiz, L; Repovic, P; Bowen, JD; Comtois, J; Uitdehaag, B; Strijbis, E; Cutter, G; Koch, MW

    Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study

    Multiple Sclerosis Journal 31 866-876. .

    [doi:10.1177/13524585251335213]

  • Leavitt, V; Mostert, J; Comtois, J; Moral, E; Brieva, L; Repovic, P; Bowen, JD; Uitdehaag, B; Strijbis, E; Cutter, G; Koch, MW

    Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy

    JOURNAL OF NEUROLOGY 272 338-338. .

    [doi:10.1007/s00415-025-13066-4]